International Stem Cell (ISCO.OB) Completes Successful Trial Launch of Lifeline Skin Care Technology

QualityStocks would like to highlight International Stem Cell (OTCBB: ISCO). The company is focused on therapeutic and research products. ISCO's core technology, parthenogenesis, results in creation of pluripotent human stem cells from unfertilized oocytes (eggs). These proprietary cells avoid ethical issues associated with use or destruction of viable human embryos and, unlike most other major stem cell types, can be immune matched and be a source of therapeutic cells with minimal rejection after transplantation into hundreds of millions of individuals of differing racial groups.

In the company’s news yesterday,

International Stem Cell Corp. announced that its wholly owned subsidiary Lifeline Skin Care Inc. (LSC) has completed its evaluation of the trial launch of its new stem-cell skin care product line and will now move forward with its general marketing program.

Lifeline Skin Care products contain parthenogenetic stem-cell extract, which were developed by the ISCO research team and recognizable cosmetic chemists. The products are designed to prevent and repair damaged skin with advanced technology. The company said sales have surpassed expectations and that it will now move forward with distribution near the end of March.

“Sales to date have greatly exceeded our expectations for the trial launch. These initial sales resulted from a very limited product offering made to subscribers of only one of the several newsletters of our marketing partner, John Mauldin, plus a small direct mailing to interested parties and ISCO’s shareholders who had signed up for general corporate information through the ISCO website,” Dr. Ruslan Semechkin, CEO of Lifeline Skin Care stated in the press release.

The distribution phase will consist initially of a customer solicitation conducted by Mauldin’s specialty Internet and direct response marketing efforts.

“We almost never endorse or sell a retail product,” Mauldin stated. “But the results of both our informal testing and the company’s formal studies have convinced us that the Lifeline Skin Care products really are a game-changing advance in skin care. I have not seen such a strong response in online marketing in the last ten years. We are all very excited and proud to be involved.”

Kenneth Aldrich, chairman of ISCO, cautioned investors on making trading decisions based on today’s news alone.

“We are incredibly excited by the prospects of this new product from our Lifeline Skin Care subsidiary,” Aldrich stated. “Selling over 7,000 bottles through a very limited trial launch, as we have done, represents a significant first step, but it would be imprudent for us to base projections of future sales or profits on a sample base of this size.”

ISCO noted that under its current revenue recognition policy, a large portion of the fourth-quarter 2010 sales will not be included as revenue in the financial statements for the year ended December 31, 2010.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 750,000+ subscribers that receive The Daily Stock Newsletters.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net

Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.